StonvexLoading…
StonvexStonvexStonvexCore line items from DTIL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $34.26M | $68.70M | $48.73M | $25.10M |
Operating Income | $-52.15M | $-26.16M | $-43.74M | $-62.31M |
Net Income | $-45.72M | $7.17M | $-61.32M | $-111.64M |
EPS (Diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 |
Total Assets | $154.42M | $136.39M | $159.78M | $238.17M |
Total Liabilities | $62.17M | $80.00M | $140.92M | $177.74M |
Cash & Equivalents | $110.82M | $85.90M | $116.68M | $189.58M |
Free Cash Flow OCF − CapEx | $-65.93M | $-58.70M | $-86.07M | $-49.07M |
Shares Outstanding | 24.09M | 8.20M | 4.16M | 3.70M |